Evidence map›Paper›PMID 41304160›Full record

ArticleMicroorganisms2025

Rare emm6.10

Laurent Blairon, Marie Tré-Hardy, Veerle Matheeussen, Sien De Koster, Marie Cassart, Sarah Heenen, Andrea Nebbioso, Nancy Vitali

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laurent BlaironDepartment of Laboratory Medicine, Iris Hospitals South, 1050 Brussels, Belgium.ORCID 0000-0003-0304-7624
Marie Tré-HardyDepartment of Pharmacy, Namur Research Institute for Life Sciences, University of Namur, 5000 Namur, Belgium.ORCID 0000-0003-4915-1339
Veerle MatheeussenNational Reference Centre for Invasive β-Hemolytic Streptococci Non-Group B, Antwerp University Hospital, 2650 Edegem, Belgium.ORCID 0000-0003-2137-2068
Sien De KosterNational Reference Centre for Invasive β-Hemolytic Streptococci Non-Group B, Antwerp University Hospital, 2650 Edegem, Belgium.ORCID 0000-0002-5267-5080
Marie CassartDepartment of Medical Imaging, Iris Hospitals South, 1050 Brussels, Belgium.ORCID 0000-0003-2766-1805
Sarah HeenenDepartment of Intensive Care Medicine, Iris Hospitals South, 1050 Brussels, Belgium.
Andrea NebbiosoDepartment of Pediatrics, Iris Hospitals South, 1050 Brussels, Belgium.ORCID 0000-0003-0330-7086
Nancy VitaliDepartment of Pediatrics, Iris Hospitals South, 1050 Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive group A streptococcal (iGAS) infections are increasingly recognized as a global public health concern, with a notable resurgence observed among pediatric populations in high-income countries following the relaxation of COVID-19-related restrictions. While the most commonly implicated emm types in invasive disease are emm1 and emm3, the global distribution of

Indexed as

childrenemm typingGroup A Streptococcusinvasive infectionperiostitis

Identifiers

PMID41304160
PMCPMC12654309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.